Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/69887
Type: Artigo de periódico
Title: Historical epidemiology of hepatitis C virus (HCV) in selected countries
Author: Bruggmann, P
Berg, T
Ovrehus, ALH
Moreno, C
Mello, CEB
Roudot-Thoraval, F
Marinho, RT
Sherman, M
Ryder, SD
Sperl, J
Akarca, U
Balik, I
Bihl, F
Bilodeau, M
Blasco, AJ
Buti, M
Calinas, F
Calleja, JL
Cheinquer, H
Christensen, PB
Clausen, M
Coelho, HSM
Cornberg, M
Cramp, ME
Dore, GJ
Doss, W
Duberg, AS
El-Sayed, MH
Ergor, G
Esmat, G
Estes, C
Falconer, K
Felix, J
Ferraz, MLG
Ferreira, PR
Frankova, S
Garcia-Samaniego, J
Gerstoft, J
Giria, JA
Goncales, FL
Gower, E
Gschwantler, M
Pessoa, MG
Hezode, C
Hofer, H
Husa, P
Idilman, R
Kaberg, M
Kaita, KDE
Kautz, A
Kaymakoglu, S
Krajden, M
Krarup, H
Laleman, W
Lavanchy, D
Lazaro, P
Marotta, P
Mauss, S
Correa, MCM
Mullhaupt, B
Myers, RP
Negro, F
Nemecek, V
Ormeci, N
Parkes, J
Peltekian, KM
Ramji, A
Razavi, H
Reis, N
Roberts, SK
Rosenberg, WM
Sarmento-Castro, R
Sarrazin, C
Semela, D
Shiha, GE
Sievert, W
Starkel, P
Stauber, RE
Thompson, AJ
Urbanek, P
van Thiel, I
Van Vlierberghe, H
Vandijck, D
Vogel, W
Waked, I
Wedemeyer, H
Weis, N
Wiegand, J
Yosry, A
Zekry, A
Van Damme, P
Aleman, S
Hindman, SJ
Abstract: Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. For some countries, data from centralized registries were used to estimate diagnosis and treatment rates. Data for the number of liver transplants and the proportion attributable to HCV were obtained from centralized databases. Viremic prevalence estimates varied widely between countries, ranging from 0.3% in Austria, England and Germany to 8.5% in Egypt. The largest viremic populations were in Egypt, with 6358000 cases in 2008 and Brazil with 2106000 cases in 2007. The age distribution of cases differed between countries. In most countries, prevalence rates were higher among males, reflecting higher rates of injection drug use. Diagnosis, treatment and transplant levels also differed considerably between countries. Reliable estimates characterizing HCV-infected populations are critical for addressing HCV-related morbidity and mortality. There is a need to quantify the burden of chronic HCV infection at the national level.
Subject: treatment
mortality
diagnosis
incidence
HCV
epidemiology
prevalence
hepatitis C
disease burden
Country: EUA
Editor: Wiley-blackwell
Rights: fechado
Identifier DOI: 10.1111/jvh.12247
Date Issue: 2014
Appears in Collections:Artigos e Materiais de Revistas Científicas - Unicamp

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.